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Purpose: This study assessed the negative predictive value, sensitivity, specificity, and diagnostic accuracy of real-time
contrast-enhanced ultrasound imaging (CEUS) in the detection of endoleaks in patients with abdominal aortic aneurysm
(AAA) who underwent endovascular repair (EVAR) compared with unenhanced ultrasound imaging. Computed
tomography angiography (CTA) was the gold standard. The secondary objective was to define the optimal dose of the
second-generation contrast agent to routinely use in the CEUS examinations for endoleak detection.
Methods: The study enrolled 84 patients with unruptured AAA who were treated with EVAR and underwent CTA
follow-up. In the same day, CTA (4-  1-mm collimation, 1.25-mm slice width), unenhanced US imaging and CEUS
imaging was performed in all patients. The CEUS studies were performed after an intravenous bolus injection of 1.2 mL
and 2.4 mL of a second-generation contrast agent with continuous low-mechanical index (range, 0.01-0.04) real-time
tissue harmonic imaging. The unenhanced US and CEUS studies were interpreted separately by two independent
experienced readers to detect the presence of endoleaks by viewing recorded videotapes according to a five-point
confidence scale. The standard of reference was represented by the consensus reading of CTA performed by two
experienced radiologists not involved in the image analysis. Qualitative analysis as well as sensitivity, specificity, negative
predictive value, and diagnostic accuracy in detecting endoleaks of each reading session were compared.
Results: CEUS imaging significantly improved the diagnostic performance of unenhanced US studies in the detection of
endoleaks in terms of sensitivity (97.5% vs 62.5%), negative predictive value (97.3% vs 65.1%), accuracy (89.3% vs 63.1%),
and specificity (81.8% vs 63.6%). The optimal dose of contrast agent to detect and characterize endoleaks was 2.4 mL. No
adverse events were recorded during the study.
Conclusions: The results showed CEUS imaging is a fast, noninvasive, reliable, and valid alternative to multislice CTA for
endoleak detection in endovascular aortic stent graft patients, and is superior to unenhanced US imaging. Contrast-
enhanced ultrasound imaging should be performed using a recommended contrast medium dose of 2.4 mL. (J Vasc Surg
2009;49:552-60.)Endovascular stent graft placement is a successful alter-
native to open vascular surgery for abdominal aortic aneu-
rysm (AAA) treatment.1-3 Although endovascular aneu-
rysm repair (EVAR) can reduce perioperative mortality, the
rate of complications and hospitalization may necessitate re-
intervention during follow-up. Patient surveillance and early
complication detection are crucial to determine the long-term
performance of these devices.
The most common complication (2% to 45%) is en-
doleak, which is the persistent perigraft flow within the
aneurysmal sac excluded by the stent graft.4-9 Persistent
endoleak is considered a procedural failure because it may
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552cause enlargement and rupture of the aneurysm, represent-
ing the main indication for surgical late conversion.10
Contrast-enhanced helical computed tomography
(CT) has shown high sensitivity for detecting endoleaks
and is considered the gold standard in the follow-up of
patients with stent graft implantation.8,9 The European
Collaborators on Stent/graft Techniques for Aortic Aneu-
rysm Repair (EUROSTAR) Registry10 recommends follow-
up consisting of CT angiography (CTA) examinations per-
formed 1, 6, and 12 months after the procedure and
subsequent annual investigations, unless complications de-
velop.
CTA has limitations, however. The investigation is
repeated several times, making radiation exposure a neces-
sary concern. As recently reported,11 and also suggested by
the American College of Radiology, the dose of unneces-
sary radiation needs to be reduced in diagnostic imaging.
Therefore, another reliable diagnostic examination during
follow-up would be useful.
Color duplex ultrasound (CDUS) imaging is noninva-
sive, does not use radiation or contrast medium, is less
expensive, easy to perform, and widely available. However,
the sensitivity of CDUS in the detection of endoleak varies
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results depend not only on the skills and experience of the
operator but also on the habitus and level of cooperation of
the patient.
Early published experience indicates that a contrast US
examination seems to improve the diagnostic sensitivity of
US imaging and its accuracy in endoleak detection.14,15
The primary objective of this prospective, single-center
study was to assess the negative predictive value, sensitivity,
specificity, and diagnostic accuracy of real-time contrast-
enhanced ultrasound (CEUS) imaging in the detection of
endoleaks in patients who underwent EVAR compared
with unenhanced US imaging using CTA as the gold
standard. The secondary objective was to define the opti-
mal dose of the second-generation contrast agent to rou-
tinely use in CEUS examinations for endoleak detection.
MATERIALS AND METHODS
Study design. The study received local ethics board
approval. Patients provided written informed consent,
waived by the ethics board, for CEUS and multidetector
CT examinations.
The study enrolled all patients treated with EVAR who
underwent CTA as part of a routine surveillance program at
1, 6, and 12 months after the procedure and annually
thereafter. They underwent CTA and CDUS and CEUS
imaging on the same day. Patients with unstable general
conditions, such as heart failure (New York Heart Associa-
tion class IV), severe chronic bronchopulmonary disorders,
severe pulmonary hypertension, or uncontrolled hyperten-
sion were excluded.
To avoid selection bias in favor of patients who were
“easy to scan,” patients were recruited before undergoing a
baseline US scan. No patient was excluded on the basis of
poor technical quality of the baseline US study.
Ultrasound imaging. The precontrast and postcon-
trast US scans were performed by a single radiologist who
was a specialist in vascular radiology and experienced in the
use of ultrasound contrast material (R. I. with 8 years of
experience). The radiologist was blinded to all other imag-
ing findings at the time of examinations.
All US scans were performed with a Philips HDI 5000
scanner (Philips Medical Systems, Bothell, Wash), equipped
with 10.4 software, with a convex multifrequency 5- to
2-MHz probe. CEUSwas performed after administration of
a second-generation contrast agent (SonoVue, Bracco, Mi-
lan, Italy) made of sulfur hexafluoride-filled microbubbles
with flexible shells that allow real-time imaging at low
acoustic pressure (mechanical index range, 0.12-0.14). Ax-
ial and longitudinal and acquisition scans were used for the
US imaging.
The CEUS scans were performed after the administra-
tion of a bolus of two different doses of contrast agent
dissolved in 0.9% saline solution (1.2mL and 2.4mL), each
followed by flushing with an injection of a 5-mL bolus of
saline solution through an 18- to 20-gauge cannula placed
in an arm vein. A minimum interval of 10 minutes and
complete bubble destruction, which was achieved by scan-ning the entire abdominal aorta at a high mechanical index,
were required between the two injections to avoid car-
ryover effects. Scanning was started at the beginning of
contrast agent injection and the sweep was usually com-
pleted within 5 minutes. The phases of CEUS were defined
as arterial (10 to 40 seconds after contrast agent injection)
and late (90 to 300 seconds after injection).
The CDUS and CEUS image data were recorded on
videotapes in digital format for subsequent analysis.
Computed tomography angiography. Triple-phase
acquisition (unenhanced and contrast-enhanced transverse
imaging, in arterial and delayed phases) was performed
using a multidetector row helical scanner (Somatom Plus 4
Volume Zoom; Siemens, Forccheim, Germany) at each
follow-up CT study. Unenhanced images were obtained
with a slice collimation of 2.5 mm, whereas a 1-mm slice
collimation was used for contrast-enhanced acquisitions,
obtained after bolus intravenous injection of 120 mL of
iodinated nonionic contrast medium (Iomeprol 300 mgI/
mL, Iomeron; Bracco) at a flow rate of 3 mL/s through an
antecubital vein. Delayed-phase acquisition, focused on the
endovascular graft, was performed 60 seconds after con-
trast medium injection.
Analysis of US images. Cine loop sweeps from the
US examinations were randomly reviewed independently by
two radiologists not involved in the imaging, one radiologist
specialized in vascular radiology (D. P. with 10 years of
experience) and the other in CEUS (R. B. with 15 years of
experience), and neither was aware of the CTA outcomes or
dose of contrast used for CEUS. They reviewed videotapes
of each patient during three different sessions:
1. The baseline unenhanced US scan—session A (CDUS),
2. CEUS after the administration of 1.2 mL of the contrast
agent—session B, low-dose contrast-enhanced (LDCE)
US imaging, and
3. CEUS after the administration of 2.4 mL contrast
medium—sessionC, high-dose contrast-enhanced (HDCE)
US imaging.
The tapes were viewed at an interval of at least 1 week to
reduce their memory of previous images. The readers were
blinded to image session sequence; furthermore, names,
ages, and identification numbers of patients, as well as
imaging parameters were always hidden during the review.
The readers independently assigned a confidence level
for endoleak diagnosis using a 5-point scale: 1, certainly
absent; 2, probably absent; 3, possibly present; 4, probably
present; and 5, certainly present. The readers were in-
formed that a confidence level of 3 or higher represented a
positive diagnosis of endoleak. In case of significant dis-
agreement between the two readers, the final decision to
modify the diagnosis was based on a second evaluation
performed in “consensus.”
For image analysis objectivity and reproducibility, stan-
dard criteria for endoleak diagnosis were provided. During
the reading session that included the baseline unenhanced
US images, the presence of endoleak was considered prob-
able or certain if a color duplex signal was present beyond
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the presence of endoleak was considered probable or cer-
tain if a high attenuation area, absent on the baseline
unenhanced-phase images, due to the presence of contrast
enhancement, was present beyond the graft but within the
aneurysm sac. The evaluation was based on visual assess-
ment, without attenuation measurements. The baseline
and CEUS images were not evaluated side by side with a
split screenmode so that the evaluation could be performed
as it would in a real practice. Readers were asked to classify
the endoleak in cases with scores of 4 or 5.
The radiologists were also asked to provide a qualitative
assessment of the visualization of various parts of the endo-
vascular stent graft at the levels of the proximal anastomo-
sis, main body of the prosthesis, right and left branch, and
right and left distal anastomosis. They used a 5-point scale:
0, not visible; 1, poor visualization; 2, sufficient visualiza-
tion; 3, adequate visualization; 4, excellent visualization.
They were also asked to provide a qualitative assessment of
the duration of contrast enhancement achieved, specifying
whether it was too brief to enable an adequate assessment
of the whole prosthesis and detection of endoleak (score 1)
or whether its duration was adequate to enable the detec-
tion of endoleak (score 2). They rated the degree of inten-
sity of vascular contrast enhancement achieved as 0, insuf-
ficient; 1, poor; 2, sufficient; 3, good; and 4, optimal.
Standard of reference. Triple-phase CT acquisition
(unenhanced, arterial and delayed phase images), assessed
in consensus by two experienced vascular radiologists
(A. R. C. and D. G., with 18 and 3 years of experience in
body CT, respectively) not involved in US image analysis,
who knew previous CT imaging findings, represented our
standard of reference for both endoleak detection and
exclusion. They established the presence/absence of en-
doleak according to a 3-point scale: 1, no leak; 2, uncertain;
and 3, presence of a leak. Patients with a score of 2 were not
considered in the evaluation.
They were asked to classify a detected leak according to
its etiology as described by White et al.16-18 All endoleaks
detected only on delayed phase were classified as low-flow
leaks.7 If a CTA diagnosis of endotension was performed or
if CTAwas not able to classify the endoleak, the standard of
reference was represented by a selective catheter angiogra-
phy performed by a senior vascular radiologist (A. R. C.).
The size of each endoleak was categorized as small
(3%), medium (3% to 10%), or large (10%) by
comparing the area of the endoleak (A(E)) with the maxi-
mum cross-sectional area of the aneurysm sac (A(A)) eval-
uated on axial images by using an electronic cursor (per-
centage size of endoleak  A(E)/A(A)).
Readers assessed changes in aneurysmal sac size (incre-
ment, stability or reduction) compared with previous CT
studies by measuring the largest diameter of the aneurysm
perpendicular to the aortic axis on the axial images using an
electronic cursor. A change was recorded if it was 5 mm.
Statistical analysis. Data were reported as mean 
standard error for continuous variables, whereas categoric
and ordinal data were reported as frequencies and percent-ages. The qualitative assessment of duration and degree of
intensity of contrast enhancement was used to establish the
correct dose; the three sessions were also qualitatively com-
pared in terms of degree of visualization of various parts of
the endovascular stent graft (5-point scale). Differences
among the three sessions in image quality score were eval-
uated by analysis of variance with generalized linear model.
Interobserver agreement for US image evaluation was
assessed with intraclass correlation, rating reliability by
comparing the variability of different ratings of the same
subject with the total variation across all ratings and sub-
jects.19
The diagnostic accuracy of each set was also estimated
by calculating the area under the receiver operating charac-
teristic curve (AUC), representing a combined measure of
sensitivity and specificity. Differences in diagnostic tests can
be evaluated by comparing AUCs,20-22 because they mea-
sure overall performance. We also evaluated differences in
AUC values between readers in the image sets using U
statistics, according to DeLong.23 Negative predictive val-
ues, sensitivity, and specificity to detect endoleaks for each
set were calculated and compared using the McNemar
test.24 Two-tailed values of P  .05 were considered sig-
nificant. Statistical analyses were done using SAS 8.2 (SAS
Institute, Cary, NC). When the CTA outcome was uncer-
tain, the US examination result was not considered.
RESULTS
Patients. The study enrolled 84 consecutive patients
(69 men, 15 women) with a mean age of 79.6 5.2 years,
(range, 62-89 years) and a mean body mass index (BMI) of
27.4 3.5 kg/m2 (range, 22-34.2 kg/m2) who underwent
endovascular repair of an unruptured infrarenal AAA. Devices
used were 81 aortobiiliac stent grafts, consisting of 43 Talent
(Medtronic AVE), 28Excluder (WLGore), 8Zenith (Cook),
1Vanguard, and 1 AneuRx (Medtronic AVE); and 3 aorto-
monoiliac stent grafts (Talent, Medtronic, AVE). The mean
follow-up after EVAR was 8.6  5.4 months (range: 1-24
months). All patients completed the protocol, and no adverse
events were recorded during CEUS or multidetector CT
examinations.
Image analysis
Gold standard. Multislice CTA detected endoleaks in
40 of 84 patients (47.6%). None of the CTAs resulted in an
uncertain diagnosis (score 2) on the presence or absence of
endoleak, so all US examinations were evaluated.
Endoleaks were classified according to the size and
etiology as summarized in Table I. In detail, two large
endoleaks were not clearly classified by CTA (differential
diagnosis between type II and type III endoleak). These
two patients underwent selective conventional angiography
that detected two type II endoleaks due to retrograde flow
into the aneurysm sac through lumbar arteries. Five small
type II endoleaks were detected only on delayed phase and
were classified as low-flow leaks.
An increase in size of the aneurysm sac associated with
endoleak was observed in all type I (1.6 cm and 1.2 cm,
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large (0.8 cm and 1 cm, respectively) and two medium type
II endoleaks (0.5 cm and 0.8 cm, respectively); in the
remaining 33 type II endoleaks, 16 aneurysm sacs were
stable and 17 decreased. In all patients diagnosed as nega-
tive for endoleak at the standard of reference, the aneurysm
sac always decreased or remained unchanged, without any
complication. Therefore, no diagnosis of endotension was
made.
Reading session. No US examination was considered
technically inadequate (no visualization of endovascular
stent graft at all different levels, score 0) due to body
habitus or collaboration of patient or other difficult scan-
ning conditions. A score of at least of 2 (sufficient visual-
ization) was obtained in all patients, except for three pa-
tients studied at the 1-month follow-up who underwent
EVAR by using a low-permeability design Gore Excluder
endoprosthesis. In these patients a poor visualization of all
studied segments was registered due to significant artifacts
with echo reflection.
The  test analysis showed excellent interobserver
agreement ( analysis value 0.89) in all reading sessions
for endoleak detection. Furthermore, there was no signifi-
cant disagreement between readers in negative vs positive
endoleak diagnosis and no second evaluation was needed to
achieve consensus. Data for the two readers were pooled
based on statistical results.
When considering true positive cases, readers detected
25 endoleaks (62.5%) in the CDUS imaging session A, 37
(92.5%) in the LDCE US session B and 39 (97.5%) in the
HDCE US session C. In detail, all 17 medium and large
leaks were correctly detected in the three sessions (Fig 1),
whereas eight of 23 small leaks were correctly detected in
the CDUS session A, 20 in the LDCEUS session B, and 22
in the HDCE US session C. In detail, the small type II
endoleak undetected at the 1-month follow-up in the
LDCE and HDCE US sessions was in one patient who
underwent EVAR with a low-permeability design Gore
Excluder endoprosthesis, with significant periprosthetic ar-
tifacts with echo reflection. The other two leaks not de-
tected with LDCE US imaging were small type II en-
doleaks from a stable aneurysm sac. All endoleaks detected
were correctly classified on both LDCE and HDCE US
Table I. Classification of detected endoleaks
Endoleak
Etiology
I
II
III IV V TotalIMA LA
Small . . . 6 17 . . . . . . . . . 23
Medium . . . 5 7 . . . . . . . . . 12
Large 2 . . . 2 1 . . . . . . 5
Total 2 11 26 1 . . . . . . 40
IMA, Inferior mesenteric artery; LA, lumbar artery.imaging.All five small low-flow endoleaks were correctly detected
inUS sessions B (LDCE) andC (HDCE),whereas nonewere
detected on CDUS imaging (false-negative cases; Fig 2).
Twenty-eight (63.6%) of 44 patients devoid of en-
doleak according to multislice CTA were classified as such
by CDUS imaging vs 35 (79.5%) by LDCE and 36 (81.8%)
by HDCE US imaging; thus, nine and eight false-positive
judgments were made with CEUS imaging. Five and four
false positive endoleaks were detected by LDCE and
HDCEUS imaging, respectively, in the arterial phase (30
seconds after contrast medium injection; Fig 3), whereas
the last four false-positive judgments on both CEUS ses-
sions were detected at 150 seconds after the contrast
medium injection and were regarded as low-flow leaks.
Two arterial-phase false-positive judgements were per-
formed at the 1-month follow-up in two patients who
underwent EVAR by using a low-permeability design Gore
Excluder endoprosthesis. The presence of significant peripros-
thetic artifacts resulted in both readers providing an uncertain
diagnosis (score 3). The diagnostic performance of CDUS
and CEUS imaging is compared in Table II.
Contrast enhancement with 1.2 mL of contrast me-
dium (LDCE) significantly improved the endoprosthesis
visualization score from 2.57 to 3 (P .05) compared with
baseline CDUS imaging. Doubling the contrast medium to
2.4 mL (HDCE) provided further significant improvement
up to 3.39 (P  .05). The improvement included all parts
of the endoprosthesis (Fig 4).
HDCE provided significantly longer contrast enhance-
ment duration than LDCE (3 minutes 42 seconds  18
seconds vs 2 minutes 47 seconds  23 seconds p  .05),
which ensured adequate enhancement for endoleak detec-
tion in 90.5% of cases vs 58.3% with the low dose. Contrast
enhancement intensity was good to optimal in 89.3% of
cases with HDCE vs 64.3% with LDCE (P  .05).
DISCUSSION
The most reliable diagnostic alternative to CTA in
post-EVAR life-long surveillance is still heavily debated.
CDUS imaging is routinely used in vascular screenings
because it is easy to perform, inexpensive, portable, safe,
and widely available. In our experience and as reported in
the literature, however, this technique performs poorly in
endoleak detection, with high false-negative and false-
positive results, principally due to echo reflection by the
metallic portion of stent graft, presence of calcifications,
meteorism, obesity, and slow endoleak flow, which does
not allow distinction of color signals coming from vessel
walls and surrounding tissue from those derived from cor-
puscular hematic components.
Conversely, this study shows CEUS imaging signifi-
cantly improves the diagnostic performance of CDUS im-
aging in endoleak detection in patients with endovascular
aortic stent grafts. Its sensitivity and negative predictive
value are similar to multislice CTA (97.5% and 97.3%,
respectively), and its specificity and accuracy are satisfactory
(81.8% and 89.3%) but not ideal because the false-positive
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evaluating aortic stent grafts by CEUS imaging vs CTA,
where sensitivity for endoleak detection was 50% to 100%,
with many false-positive results.25-29
Napoli et al,30 however, reported 10 men with aneu-
rysm enlargement and no evidence of endoleak during
color-coded DUS imaging or CTA in whom CEUS scans
performed with SonoVue detected endoleaks confirmed by
conventional angiography. The authors suggest that CTA
failure may have resulted from shorter imaging duration
than with CEUS imaging; other published data have also
confirmed14 that CEUS imaging seems to be more sensi-
tive than CTA in diagnosing low-flow endoleaks.
Consequently, the four false-positive endoleaks de-
Fig 1. A 74-year-old man treated with endovascular an
correctly detected on color duplex ultrasound imaging
confirmed by standard of reference.
Fig 2. An 82-year-old man treated with endovascular a
duplex ultrasound image did not demonstrate any color
diagnosis for endoleak. b, The contrast-enhanced ultraso
after contrast injection which was regarded as a low-flow
a small endoleak on the posterolateral side of the aneury
leak) (arrows in panel d).tected in our experience at 150 seconds after contrastmedium injection and regarded as low-flow leaks could be
false-negative multidetector CT diagnoses, with a conse-
quent potential increase of CEUS diagnostic accuracy.
On the other hand, three false-positive arterial en-
doleaks detected on US imaging with LDCE and two with
HDCE were due to a baseline high attenuation of the
thrombus not completely recognized on the baseline US
scan (Fig 3). These uncorrected diagnoses could be
avoided with an evaluation of baseline and contrast-
enhanced US images performed side by side with a split
screen mode, but this cannot be easily implemented in
clinical practice. We would like to emphasize that to reduce
false-positive diagnoses, an accurate baseline US examina-
tion before contrast medium injection must be performed,
m repair (6-month follow-up). a, A large endoleak was
(b) contrast-enhanced ultrasound images, and (c) was
ysm repair at 1-month follow-up. a, The baseline color
lex signal beyond the graft, with a consequent negative
image showed a small endoleak (arrows) at 150 seconds
c and d, Standard of reference confirmed the presence of
etected only on delayed phase axial CT image (low-floweurys
andneur
dup
und
leak.
sm, dmainly to assess the morphology of the aneurysmal sac.
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endoleaks on CEUS imaging, as well as one false-negative
undetected small endoleak, were found at the 1-month
follow-up in three patients who underwent EVAR by using
a low-permeability design Gore Excluder endoprosthesis.
This innovative device, introduced in 2002, is composed of
a durable, reinforced expanded polytetrafluoroethylene
(ePTFE) graft, low permeability material layer, electropol-
Fig 3. A 78-year-old woman treated with endovascula
enhanced ultrasound image shows a high attenuation are
an endoleak was diagnosed. b, However, no endoleak w
tomography images. d, An accurate evaluation of the bas
a high attenuation of the thrombus outside the stent
endoleak.
Table II. Diagnostic performance of color duplex and
contrast-enhanced ultrasound imaging in endoleak
detection using multislice computed tomography as
a reference
Diagnostic parameter
Type of ultrasound imaging
CD LDCE HDCE
Negative predictive value, % 65.1 92.1a 97.3a
Sensitivity, % 62.5 92.5a 97.5a
Specificity, % 63.6 79.5a 81.8a
Accuracy, % 63.1 85.7a 89.3a
Az index 0.737 0.921a 0.971a
CD, color duplex; LDCE, low-dose contrast-enhanced; HDCE, high-dose
contrast-enhanced;Az index, area under the receiver operating characteristic
curve.
aSignificantly higher than rate achieved with color duplex ultrasound imag-
ing (P  .05).ished nitinol stent, and bonding film for stent to graftattachment. Its unique graft design reduces the potential
for serous fluid movement through the graft wall, with
consequent endotension. However, the ePTFE graft mate-
rial produces significant artifacts with echo reflection at
1-month follow-up, explaining our erroneous diagnosis;
these artifacts usually disappear at the 6-month follow-up.
Recent preliminary data31 suggest that CEUS imaging
is more specific than CTA in endoleak classification thanks
to longer duration of enhancement, lack of metallic arti-
facts, and angio-dynamic evaluation of the leak during the
dynamic phase, as also demonstrated in our experience (Fig
5). CEUS advantages include minimal invasiveness, rapid-
ity, and good tolerability: no adverse events were registered
in our study.
On the other hand, CEUS imaging also has some
limitations. Patient habitus (obesity) and bowel gas can
interfere with imaging, and the patient must cooperate.
The results of the US are operator-dependent, and obtain-
ing quality images requires training and specific skills. Fur-
thermore, CTA provides superior information related to
graft anchoring and integrity, aneurysm morphologic
changes, or visceral vessels patency (renal arteries).32
Therefore, CEUS should replace CTA at the 6-month
follow-up and annually thereafter. In fact, in our opinion,
the rationale of post-EVAR follow-up at 1-month and
12-month follow-up should be to detect endoleaks as well
rysm repair at the 12-month follow-up. a, A contrast-
side the graft (arrows) but within the aneurysm sac, and
tected on axial arterial and (c) delayed-phase computed
color duplex ultrasound image allows the recognition of
lumen (arrows) excluding the previous false-positiver aneu
a out
as de
eline
graftas to evaluate intraprocedural and periprocedural compli-
JOURNAL OF VASCULAR SURGERY
March 2009558 Iezzi et alcations related to stent graft anchoring and visceral vessels
patency and postprocedural complications related to stent
graft migration and integrity, visceral vessels patency, and
aneurysm morphologic changes, respectively. On the basis
of this opinion, our suggested follow-up is based on CTA at
1 and 12 months after EVAR, with CEUS imaging per-
formed at 6 months and annually thereafter, if no compli-
cations are detected.
The main strength of this study is that a large number
of consecutive patients have been included. Our study also
differs from others in literature for the attempt to define the
optimal US contrast agent dose, which is not yet clearly
defined for vascular examinations and stent-graft follow-up
treatment.30,33,34 Our findings show that 2.4 mL is pre-
ferred to 1.2 mL because it provides significantly better
results in intensity and duration of contrast enhancement
Fig 4. Qualitative evaluation of endoprosthesis visua
enhanced ultrasound imaging (CEUS) with 1.2 mL (di
mosis; Br, branch; Prox, proximal.
Fig 5. A 71-year-old man treated with endovascular a
located in a posterolateral position was shown on the (a
images, associated with (c) opacification of a lumbar arte
strictly adjacent to the prosthesis, with a consequent
classification of the endoleak was not clearly performed
evaluation of dynamic contrast-enhanced ultrasound ima
sac via lumbar artery, excluding a concomitant type III en
arrows in f and asterisk in g).and, consequently, in visualization than the low dose.A potential limitation of our study could be the lack of
a proper gold standard. However, as also reported in the
literature, triple-phase CT acquisition—including unen-
hanced, 1-mm-slice arterial and delayed-phase images, with
added clinical data (aneurysmal sac size change compared
with previous CT exams)—seems to be the best gold stan-
dard in patient follow-up of patients who underwent
EVAR. On the other hand, it could be interesting to
check with selective digital angiography the patients that
were negative by CTA but positive by CEUS imaging to
confirm or deny the presence of an endoleak in order to
define the real gold standard. However, in all patients in
our study diagnosed as negative for endoleak at CTA, the
aneurysm sac always decreased or remained unchanged,
without any complication. These findings did not clini-
cally justify the potential procedural risk of performing
n scores for color duplex (gray bars), and contrast-
l-patterned bars) and 2.4 mL (dark gray). An, Anasto-
sm repair at the 1-month follow-up. A large endoleak
three-dimensional and (b) axial computed tomography
ssified as a type II endoleak. However, the leak was also
ble diagnosis of a concomitant type III endoleak. A
the basis of the computed tomography images. d, An
emonstrated the back-filling of the excluded aneurysmal
k, as confirmed by digital subtraction angiography (e-g,lizatio
agonaneury
, c)
ry, cla
possi
on
ges d
doleaangiography.
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 3 Iezzi et al 559Another potential limitation is based on the performed
measurement of the size of the endoleak; in detail, a volu-
metric classification of size of the endoleaks could be more
accurate than the comparison of the area with the maxi-
mum cross-sectional area of the aneurysm sac. Volume
assessment is time-consuming, however, and requires ad-
vanced processing, dedicated equipment, and skilled oper-
ators; furthermore, as reported in the literature, the indica-
tion for treatment is based on the etiology of endoleaks and
on the aneurysm diameter changes: as a matter of fact, an
accurate classification of size of the endoleaks seems not to
be clinically relevant.
In conclusion, CEUS is a fast, minimally invasive, reli-
able, and valid alternative to multislice CTA for endoleak
detection in patients with endovascular aortic stent graft,
and is superior to CDUS imaging. On the basis of our
study, CEUS should be performed using a recommended
contrast medium dose of 2.4 mL.
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